Efficacy can be low but safety should not be compromised: Bharat Biotech chief : News Reel: Business Today
Business Today
Loading...
 

Efficacy can be low but safety should not be compromised: Bharat Biotech chief

Rajeev Dubey | January 6, 2021

Dr Krishna Ella, Chairman of Bharat Biotech, said that unlike the clinical trials of AstraZeneca vaccine (which has been licensed to Serum Institute of India), Bharat Biotech did not try to suppress the side effects of vaccine by giving paracetamol to the volunteers. He also said that for his company safety came first. Watch him in conversation with Rajeev Dubey, Editor, Business Today.

Also Read: China denies entry to WHO team investigating COVID-19 origins



    More from this section